Radioimmunoassay for danazol in human and monkey plasma.

Area of Science:

• Pharmacology
• Analytical Chemistry
• Biochemistry

Background:

• Danazol is a medication used for various conditions.
• Accurate quantification of danazol in biological samples is crucial for pharmacokinetic and therapeutic drug monitoring.
• Existing methods may lack the sensitivity or specificity required for precise measurement.

Purpose of the Study:

• To develop and validate a sensitive radioimmunoassay (RIA) for danazol in plasma.
• To assess the specificity and detection limits of the developed RIA.
• To evaluate the assay's accuracy in quantifying exogenous danazol in both animal and human plasma.

Main Methods:

• Development of rabbit antiserum against danazol.
• Utilizing a second antibody for separation of bound and free danazol.
• Validation of the RIA method using monkey and human plasma samples.
• Comparison with inverse isotope dilution method in monkeys.

Main Results:

• The radioimmunoassay demonstrated high specificity for danazol.
• The assay achieved a detection limit ranging from 1.4 to 2.8 ng/ml.
• Accurate quantification of exogenous danazol was achieved in both monkey and human plasma.
• RIA results showed good agreement with the inverse isotope dilution method.

Conclusions:

• A sensitive and specific radioimmunoassay for danazol in plasma has been successfully developed.
• The assay is suitable for accurate quantification of danazol in pharmacokinetic and clinical studies.
• This method enables reliable measurement of danazol levels in human plasma, even at low concentrations.